Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Change from the centre of gravity at 5 weeks and 13 weeks |
Static balance and postural control is the ability to maintain the centre of gravity within the base of support. Centre of gravity is measured in percentage through posturography study |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Primary |
Change from the monopodal stance test at 5 weeks and 13 weeks |
Static balance and postural control is the ability to maintain the centre of gravity within the base of support. Monopodal stance test measures static balance in percentage through posturography study. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Primary |
Change from Berg Balance Scale at 5 weeks and 13 weeks |
Dynamic balance is the ability to maintain the centre of gravity within the base of support during the performance of functional activities. Berg Balance scale measures dynamic balance through performing multiple tasks and with a score of 0 to 56. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Primary |
Change from Time Up and Go test at 5 weeks and 13 weeks |
Time up and Go test measures dynamic balance showed in seconds |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Primary |
Change from 10 meter walk test at 5 weeks and 13 weeks |
10 meter walk test measures walking speed and performance which is related to dynamic balance. The unit use is meter/second. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Primary |
Change from Health Assessement Questionnaire at 5 weeks and 13 weeks |
Health Assessement questionnaire measures the functional capacity of a subject. It provides an impairment score of 0 to 3. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Primary |
Change from physical function item of the Spanish Fibromyalgia Impact Questionnaire at 5 weeks and 13 weeks |
The physical function item of the Spanish Fibromyalgia Impact Questionnaire measures functional capacity with a score of 0 to 3. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Secondary |
Change from the Spanish Fibromyalgia Impact Questionnaire at 5 weeks and 13 weeks |
The Spanish Fibromyalgia Impact Questionnaire measures the quality of life and the impact of Fibromyalgia on the life of persons diagnosed with this condition. The maximum score is 100 and the higher the result obtained, the higher the impact of the condition on the person and the less quality of life he/she has. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Secondary |
Change from pain intensity levels measured with the visual analogue scale at 5 weeks and 13 weeks |
The visual analogue scale is a 100-mm scale, where 0 indicated 'no symptoms' and 100 indicating 'extreme and unbearable symptoms'. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Secondary |
Change from joint stiffness levels measured with the visual analogue scale at 5 weeks and 13 weeks |
The visual analogue scale is a 100-mm scale, where 0 indicated 'no symptoms' and 100 indicating 'extreme and unbearable symptoms'. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Secondary |
Change from depression level measured with the visual analogue scale at 5 weeks and 13 weeks |
The visual analogue scale is a 100-mm scale, where 0 indicated 'no symptoms' and 100 indicating 'extreme and unbearable symptoms'. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|
Secondary |
Change from perceived difficulty to work measured with the visual analogue scale at 5 weeks and 13 weeks |
The visual analogue scale is a 100-mm scale, where 0 indicated 'no difficulty' and 100 indicating 'extreme and unbearable difficulty'. |
Before treatment, after 5 weeks of treatment and after 6 weeks of follow up |
|